MEDICAL PROPERTIES TRUST INC (MPW) Stock Fundamental Analysis

NYSE:MPW • US58463J3041

5.02 USD
-0.03 (-0.59%)
At close: Jan 30, 2026
5.03 USD
+0.01 (+0.2%)
After Hours: 1/30/2026, 8:07:14 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Taking everything into account, MPW scores 3 out of 10 in our fundamental rating. MPW was compared to 122 industry peers in the Diversified REITs industry. There are concerns on the financial health of MPW while its profitability can be described as average. While showing a medium growth rate, MPW is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year MPW has reported negative net income.
  • In the past year MPW had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: MPW reported negative net income in multiple years.
  • MPW had a positive operating cash flow in each of the past 5 years.
MPW Yearly Net Income VS EBIT VS OCF VS FCFMPW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

1.2 Ratios

  • With a Return On Assets value of -4.74%, MPW is not doing good in the industry: 81.45% of the companies in the same industry are doing better.
  • The Return On Equity of MPW (-15.19%) is worse than 77.42% of its industry peers.
  • MPW has a Return On Invested Capital of 2.76%. This is comparable to the rest of the industry: MPW outperforms 49.19% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for MPW is in line with the industry average of 3.08%.
  • The last Return On Invested Capital (2.76%) for MPW is above the 3 year average (2.26%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -4.74%
ROE -15.19%
ROIC 2.76%
ROA(3y)-5.11%
ROA(5y)-1.92%
ROE(3y)-15.57%
ROE(5y)-6.62%
ROIC(3y)2.26%
ROIC(5y)2.99%
MPW Yearly ROA, ROE, ROICMPW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

  • Looking at the Operating Margin, with a value of 53.48%, MPW belongs to the top of the industry, outperforming 95.97% of the companies in the same industry.
  • MPW's Operating Margin has declined in the last couple of years.
  • MPW has a Gross Margin of 96.07%. This is amongst the best in the industry. MPW outperforms 97.58% of its industry peers.
  • In the last couple of years the Gross Margin of MPW has remained more or less at the same level.
Industry RankSector Rank
OM 53.48%
PM (TTM) N/A
GM 96.07%
OM growth 3Y-16.71%
OM growth 5Y-10.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y-0.02%
MPW Yearly Profit, Operating, Gross MarginsMPW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MPW is destroying value.
  • Compared to 1 year ago, MPW has more shares outstanding
  • Compared to 5 years ago, MPW has more shares outstanding
  • MPW has a worse debt/assets ratio than last year.
MPW Yearly Shares OutstandingMPW Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
MPW Yearly Total Debt VS Total AssetsMPW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

  • MPW has an Altman-Z score of 0.02. This is a bad value and indicates that MPW is not financially healthy and even has some risk of bankruptcy.
  • MPW has a Altman-Z score of 0.02. This is in the lower half of the industry: MPW underperforms 75.00% of its industry peers.
  • MPW has a Debt/Equity ratio of 2.06. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of MPW (2.06) is worse than 70.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.06
Debt/FCF N/A
Altman-Z 0.02
ROIC/WACC0.45
WACC6.13%
MPW Yearly LT Debt VS Equity VS FCFMPW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

  • A Current Ratio of 2.00 indicates that MPW should not have too much problems paying its short term obligations.
  • MPW's Current ratio of 2.00 is amongst the best of the industry. MPW outperforms 82.26% of its industry peers.
  • MPW has a Quick Ratio of 2.00. This is a normal value and indicates that MPW is financially healthy and should not expect problems in meeting its short term obligations.
  • MPW's Quick ratio of 2.00 is amongst the best of the industry. MPW outperforms 82.26% of its industry peers.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 2
MPW Yearly Current Assets VS Current LiabilitesMPW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 43.50% over the past year.
  • Looking at the last year, MPW shows a very strong growth in Revenue. The Revenue has grown by 45.56%.
  • Measured over the past years, MPW shows a small growth in Revenue. The Revenue has been growing by 3.11% on average per year.
EPS 1Y (TTM)43.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.3%
Revenue 1Y (TTM)45.56%
Revenue growth 3Y-13.62%
Revenue growth 5Y3.11%
Sales Q2Q%5.18%

3.2 Future

  • The Earnings Per Share is expected to grow by 27.42% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, MPW will show a small growth in Revenue. The Revenue will grow by 2.08% on average per year.
EPS Next Y85.75%
EPS Next 2Y42.83%
EPS Next 3Y27.42%
EPS Next 5YN/A
Revenue Next Year-4.36%
Revenue Next 2Y1.29%
Revenue Next 3Y3.17%
Revenue Next 5Y2.08%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MPW Yearly Revenue VS EstimatesMPW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
MPW Yearly EPS VS EstimatesMPW Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MPW. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 47.34 indicates a quite expensive valuation of MPW.
  • Based on the Price/Forward Earnings ratio, MPW is valued a bit cheaper than the industry average as 64.52% of the companies are valued more expensively.
  • MPW's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.01.
Industry RankSector Rank
PE N/A
Fwd PE 47.34
MPW Price Earnings VS Forward Price EarningsMPW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

  • MPW's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.92
MPW Per share dataMPW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • MPW's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • MPW's earnings are expected to grow with 27.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.83%
EPS Next 3Y27.42%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 7.17%, MPW is a good candidate for dividend investing.
  • MPW's Dividend Yield is a higher than the industry average which is at 6.88.
  • MPW's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 7.17%

5.2 History

  • The dividend of MPW decreases each year by -10.38%.
  • MPW has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-10.38%
Div Incr Years0
Div Non Decr Years0
MPW Yearly Dividends per shareMPW Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • The earnings of MPW are negative and hence is the payout ratio. MPW will probably not be able to sustain this dividend level.
DP-27.26%
EPS Next 2Y42.83%
EPS Next 3Y27.42%
MPW Yearly Income VS Free CF VS DividendMPW Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

More info and screens

Find the best dividend stocksShow peers with best dividend

MEDICAL PROPERTIES TRUST INC

NYSE:MPW (1/30/2026, 8:07:14 PM)

After market: 5.03 +0.01 (+0.2%)

5.02

-0.03 (-0.59%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-30
Earnings (Next)02-19
Inst Owners57.85%
Inst Owner Change1.85%
Ins Owners17.26%
Ins Owner Change18.96%
Market Cap3.02B
Revenue(TTM)933.52M
Net Income(TTM)-707.95M
Analysts51.76
Price Target5.27 (4.98%)
Short Float %30.26%
Short Ratio22.68
Dividend
Industry RankSector Rank
Dividend Yield 7.17%
Yearly Dividend0.54
Dividend Growth(5Y)-10.38%
DP-27.26%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-873.24%
Min EPS beat(2)-1816.17%
Max EPS beat(2)69.68%
EPS beat(4)1
Avg EPS beat(4)-3643.79%
Min EPS beat(4)-11757.5%
Max EPS beat(4)69.68%
EPS beat(8)2
Avg EPS beat(8)-2173.83%
EPS beat(12)2
Avg EPS beat(12)-1482.28%
EPS beat(16)6
Avg EPS beat(16)-1094.33%
Revenue beat(2)2
Avg Revenue beat(2)1.43%
Min Revenue beat(2)0.7%
Max Revenue beat(2)2.15%
Revenue beat(4)3
Avg Revenue beat(4)1.19%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)5.51%
Revenue beat(8)5
Avg Revenue beat(8)0.69%
Revenue beat(12)6
Avg Revenue beat(12)-0.69%
Revenue beat(16)7
Avg Revenue beat(16)-1.26%
PT rev (1m)0.46%
PT rev (3m)6.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25%
EPS NY rev (1m)0%
EPS NY rev (3m)-44.66%
Revenue NQ rev (1m)-0.44%
Revenue NQ rev (3m)0.4%
Revenue NY rev (1m)-0.47%
Revenue NY rev (3m)0.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 47.34
P/S 3.23
P/FCF N/A
P/OCF 20.49
P/B 0.65
P/tB 0.65
EV/EBITDA 15.92
EPS(TTM)-1
EYN/A
EPS(NY)0.11
Fwd EY2.11%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.25
OCFY4.88%
SpS1.55
BVpS7.75
TBVpS7.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.74%
ROE -15.19%
ROCE 3.49%
ROIC 2.76%
ROICexc 2.84%
ROICexgc 2.95%
OM 53.48%
PM (TTM) N/A
GM 96.07%
FCFM N/A
ROA(3y)-5.11%
ROA(5y)-1.92%
ROE(3y)-15.57%
ROE(5y)-6.62%
ROIC(3y)2.26%
ROIC(5y)2.99%
ROICexc(3y)2.3%
ROICexc(5y)3.06%
ROICexgc(3y)2.37%
ROICexgc(5y)3.14%
ROCE(3y)2.86%
ROCE(5y)3.79%
ROICexgc growth 3Y-18.25%
ROICexgc growth 5Y-8.72%
ROICexc growth 3Y-18.71%
ROICexc growth 5Y-8.92%
OM growth 3Y-16.71%
OM growth 5Y-10.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y-0.02%
F-Score5
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 2.06
Debt/FCF N/A
Debt/EBITDA 12.51
Cap/Depr 69.46%
Cap/Sales 20.04%
Interest Coverage 1.08
Cash Conversion 19.18%
Profit Quality N/A
Current Ratio 2
Quick Ratio 2
Altman-Z 0.02
F-Score5
WACC6.13%
ROIC/WACC0.45
Cap/Depr(3y)171.64%
Cap/Depr(5y)740.47%
Cap/Sales(3y)50.73%
Cap/Sales(5y)169.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.3%
EPS Next Y85.75%
EPS Next 2Y42.83%
EPS Next 3Y27.42%
EPS Next 5YN/A
Revenue 1Y (TTM)45.56%
Revenue growth 3Y-13.62%
Revenue growth 5Y3.11%
Sales Q2Q%5.18%
Revenue Next Year-4.36%
Revenue Next 2Y1.29%
Revenue Next 3Y3.17%
Revenue Next 5Y2.08%
EBIT growth 1Y1889.1%
EBIT growth 3Y-28.05%
EBIT growth 5Y-7.83%
EBIT Next Year118.66%
EBIT Next 3Y36.12%
EBIT Next 5Y20.09%
FCF growth 1Y70.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-73.27%
OCF growth 3Y-32.88%
OCF growth 5Y-13.06%

MEDICAL PROPERTIES TRUST INC / MPW FAQ

What is the fundamental rating for MPW stock?

ChartMill assigns a fundamental rating of 3 / 10 to MPW.


Can you provide the valuation status for MEDICAL PROPERTIES TRUST INC?

ChartMill assigns a valuation rating of 2 / 10 to MEDICAL PROPERTIES TRUST INC (MPW). This can be considered as Overvalued.


Can you provide the profitability details for MEDICAL PROPERTIES TRUST INC?

MEDICAL PROPERTIES TRUST INC (MPW) has a profitability rating of 4 / 10.


Can you provide the financial health for MPW stock?

The financial health rating of MEDICAL PROPERTIES TRUST INC (MPW) is 2 / 10.


What is the expected EPS growth for MEDICAL PROPERTIES TRUST INC (MPW) stock?

The Earnings per Share (EPS) of MEDICAL PROPERTIES TRUST INC (MPW) is expected to grow by 85.75% in the next year.